Published in Cancer Weekly, November 30th, 2004
According to recent research from the United States, "the formation of new blood vessels (angiogenesis) is a feature common to all solid tumors. The integrin receptor alpha(v)beta(3), which is found on endothelial cells lining newly growing blood vessels at a higher density than on mature blood vessels, is being explored as a marker for tumor angiogenesis. Bitistatin, a member of the disintegrin family of polypeptides, has affinity for alpha(v)beta(3) integrins."
"To determine whether radiolabeled bitistatin could target tumors, its biodistribution was tested in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.